Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial

Mahboob Rahman; Lawrence J. Appel

doi:10.1053/j.ajkd.2007.10.005

Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial

Mahboob Rahman, Lawrence J. Appel

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	901-903
Number of pages	3
Journal	American Journal of Kidney Diseases
Volume	50
Issue number	6
DOIs	https://doi.org/10.1053/j.ajkd.2007.10.005
State	Published - Dec 2007

ASJC Scopus subject areas

Nephrology

Access to Document

10.1053/j.ajkd.2007.10.005

Cite this

@article{159e62591e224d79a9551b69361f724f,

title = "Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial",

author = "Mahboob Rahman and Appel, {Lawrence J.}",

note = "Funding Information: Financial Disclosure: Dr Rahman reports that his institution received research support grants from King Pharmaceuticals and Astra-Zeneca; Dr Appel reports having received research support from King Pharmaceuticals.",

year = "2007",

month = dec,

doi = "10.1053/j.ajkd.2007.10.005",

language = "English (US)",

volume = "50",

pages = "901--903",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial

AU - Rahman, Mahboob

AU - Appel, Lawrence J.

N1 - Funding Information: Financial Disclosure: Dr Rahman reports that his institution received research support grants from King Pharmaceuticals and Astra-Zeneca; Dr Appel reports having received research support from King Pharmaceuticals.

PY - 2007/12

Y1 - 2007/12

UR - http://www.scopus.com/inward/record.url?scp=36248982065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248982065&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2007.10.005

DO - 10.1053/j.ajkd.2007.10.005

M3 - Editorial

C2 - 18037089

AN - SCOPUS:36248982065

SN - 0272-6386

VL - 50

SP - 901

EP - 903

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 6

ER -

Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this